摘要 |
Compounds of formula I as well as pharmaceutically acceptable salts and esters thereof, wherein R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP>, A<SUP>1 </SUP>and A<SUP>2 </SUP>have the significance given in claim 1 , can be used in the form of pharmaceutical preparations for the treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders and obesity.
|